Milestones

• 2007
  • SunWay Biotech Co., LTD. was established and its facility was qualified for GMP certification.
• 2008
  • The research and technology of Monascus purpureus NTU 568 (red yeast) and Lactobacillus paracasei subsp. paracasei NTU 101 (probiotics) were exclusively authorized by National Taiwan University.
  • Red yeast (Monascus purpureus) beverages were awarded the Certification of Symbol of National Quality (SNQ).

• 2009
  • Developing red yeast products in capsule
• 2010
  • Probiotic products were awarded the Certification of Symbol of National Quality (SNQ).
  • Red yeast capsulate products were granted the Certification of Halal and the US federal trademark “HCW”.

• 2011
  • The fermented manufacturing processes of red yeast-related products were granted patents and certificates from multiple nations.

• 2012
  • The main facility was expanded and certified with ISO 22000 and HACCP.
  • Application and development of non-active Lactobacillus, collagen powder, and herbal tablets.

• 2013
  • A red yeast product (ANKASCIN 568) was granted the Health Food Permit (No. A00231).

• 2014
  • Development of Lactobacillus soft sweets.
• 2015
  • The red yeast extract (ANKASCIN 568-R) was accepted by the US FDA as an NDI (New Dietary Ingredient)
  • Two clinical trials were completed in Taiwan, demonstrating ANKASCIN 568 Plus+ was effective in lowering blood glucose and blood lipids (total cholesterol and low-density lipoprotein cholesterol)
  • Red yeast and Lactobacillus ingredient supply and contract manufacturing of private label finished products.

• 2016
  • Acquired health claim certificate for new red yeast capsules in Taiwan
  • Clinical results on red yeast ingredient’s blood sugar effects were accepted by a peer-reviewed journal
  • Accomplished clinical trial on the probiotic Vigiis 101-LAB ingredient (gut microbiota effects)

• 2017
  • Acquired 2nd health claim certificate for new red yeast capsules in Taiwan
  • A food supplement containing ANKASCIN® 568-R was approved by Italian authorities
  • Clinical results on red yeast ingredient’s blood pressure effects were accepted by a peer-reviewed journal
  • SunWay’s management system has been certified by TÜV Rheinland
  • Established Songshan Lake SunWay Biotechnology in Dongguan, Guangdong
  • Initial public offering

• 2018
  • Owing to our new safety data, US FDA approved new NDI (#1071) for ANKASCIN 568-R
  • Accomplished clinical trials on the probiotic Vigiis 101-LAB ingredient’s (gut transition effects)

    

• 2019
  • Obtained D & B’s business operation capability certification
  • Cooperate with NTU Hospital to conduct clinical trials related to probiotics and H. pylori
  • NTU 101 is honored to be as the cover of Food & Function Journal
  • Red yeast rice ANKASCIN 568-R was invited to write a review
  • New red yeast rice raw material 568-P developed

    

• 2020
  • Taiwanese product red yeast rice won the Taiwan Health Food Society Nutrition and Health Food Innovation Award
  • SunWay is awarded “Taiwan BIO Awards- Emerging Company of the Year“
  • Cooperation with Belgium distributor

  

• 2021
  • SunWay is listed on Taiwan Emerging Stock Market
  • Cooperation with US Florida brand owner

• 2022
  • Being a member of the International Probiotics Association and increase exchanges of international academic and and networking for future collaborations.
  • US Red Yeast Rice product has been recognized as Finalist at NutraIngredients USA Awards 2022
  • Taiwan red yeast rice product has been awarded the Certification of Symbol of National Quality (SNQ).
  • SunWay is awarded the Gold Award of 2022 Taiwan BIO Award